Jan 08, 2024 / 10:15PM GMT
Robbie Marcus JPMorgan Chase&Co-Analyst
Great. Welcome, everyone. I'm Robbie Marcus, Medtech analyst at JPMorgan. And really happy to introduce our next session, itâs going to be CONMED introducing Curt Hartman, CEO; and Todd Garner, the CFO. Curt, I'll turn it over to you and we'll do some Q&A after.
Curt Hartman CONMED Corporation-Chair of the Board - President, CEO
Thank you, Robbie, and good afternoon, everybody. Appreciate you all being here with us today. Our opportunity to present to you on behalf of CONMED Corporation, we have the forward-looking information slide, I'll let you prove that for a moment, and then we'll jump right in here. We always like to start our presentations with comments division.
At the essence of it is empowering health care providers worldwide with the ability to deliver exceptional outcomes. We underpin that with the focus behind the vision, which is really about our people, our products and ultimately that leads to profitability.
And underneath that, we have
Conmed Corp at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot